Breaking News Instant updates and real-time market news.

PBYI

Puma Biotechnology

$90.90

-3.05 (-3.25%)

06:49
01/24/18
01/24
06:49
01/24/18
06:49

Cowen downgrades Puma Biotechnology on 'unlikely' EU approval

Cowen analyst Chris Shibutani downgraded Puma Biotechnology to Market Perform from Outperform and cut his price target for the shares to $68 from $123. The Committee for Medicinal Products for Human Use's negative trend vote makes an approval in Europe "unlikely," Shibutani tells investors in a research note. The analyst is now more cautious on Puma's regulatory prospects outside the U.S. and sees less strategic options for management.

PBYI Puma Biotechnology
$90.90

-3.05 (-3.25%)

01/17/18
SBSH
01/17/18
NO CHANGE
Target $164
SBSH
Buy
Puma Biotechnology selloff yesterday a buying opportunity, says Citi
Citi analyst Yigal Nochomovitz recommends using yesterday's selloff in shares of Puma Biotechnology as a buying opportunity. The analyst does not believe the 8% pullback is company-specific given the weakness yesterday in the sector. Nochomovitz says he found additional favorable regulatory precedent for a positive Committee for Medicinal Products for Human Use opinion for neratinib. He continues to expect a positive CHMP opinion in February and sees "another very good opportunity" to get into the name before a key expected positive catalyst. Nochomovitz has a Buy rating on Puma with a $164 price target.
01/22/18
FBCO
01/22/18
NO CHANGE
Target $147
FBCO
Outperform
Puma Biotechnology price target raised to $147 from $142 at Credit Suisse
Credit Suisse analyst Alethia Young raised her price target for Puma Biotechnology to $147 from $142, citing valuation and tax rate. The analyst reiterates an Outperform rating on the shares.
01/24/18
SBSH
01/24/18
NO CHANGE
Target $146
SBSH
Buy
Citi cuts Puma target to $146, says 'all may not be lost' in Europe
Citi analyst Yigal Nochomovitz lowered his price target for Puma Biotechnology to $146 from $164 after the company announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency communicated a negative trend vote for neratinib. The stock in premarket trading is down 28%, or $25.10, to $65.80. "Obviously the negative trend vote comes as a big surprise to us and many investors," Nochomovitz tells investors in a research note partially titled "Much Tougher Situation, But All May Not Be Lost in EU." He believes a re-examination without new data "may be challenging." As such, the analyst thinks Puma will have a much better chance in Europe once it can submit the additional data from the budesonide and colestipol Control cohorts. His new price target reflects a 45% chance of eventual approval in the Europe given the new circumstances. Nochomovitz keeps a Buy rating on Puma Biotechnology.
01/24/18
COWN
01/24/18
DOWNGRADE
COWN
Market Perform
Puma Biotechnology downgraded to Market Perform from Outperform at Cowen

TODAY'S FREE FLY STORIES

AMAT

Applied Materials

$56.66

1.63 (2.96%)

06:16
02/21/18
02/21
06:16
02/21/18
06:16
Conference/Events
Applied Materials management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 26

    Feb

  • 30

    May

EADSY

Airbus

$29.67

0.08 (0.27%)

, BA

Boeing

$353.35

-1.69 (-0.48%)

06:16
02/21/18
02/21
06:16
02/21/18
06:16
Periodicals
Qatar considering upgrading some A350 orders to larger model, Reuters reports »

Qatar Airways is…

EADSY

Airbus

$29.67

0.08 (0.27%)

BA

Boeing

$353.35

-1.69 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 30

    May

ETSY

Etsy

$21.31

0.35 (1.67%)

06:15
02/21/18
02/21
06:15
02/21/18
06:15
Recommendations
Etsy analyst commentary  »

Etsy price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 20

    Mar

AUDVF

Audi AG

, VLKAY

Volkswagen

$41.00

-1.54 (-3.62%)

06:14
02/21/18
02/21
06:14
02/21/18
06:14
Periodicals
Audi CEO rejects suggestions he is to be ousted, Reuters reports »

Rupert Stadler, the CEO…

AUDVF

Audi AG

VLKAY

Volkswagen

$41.00

-1.54 (-3.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

Dish

$44.57

-1.12 (-2.45%)

06:13
02/21/18
02/21
06:13
02/21/18
06:13
Earnings
Dish reports Q4 EPS $2.64, may not compare to consensus 55c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CNC

Centene

$100.26

0.04 (0.04%)

, MOH

Molina Healthcare

$71.86

-0.26 (-0.36%)

06:13
02/21/18
02/21
06:13
02/21/18
06:13
Recommendations
Centene, Molina Healthcare, WellCare analyst commentary  »

Piper sees 'ideal…

CNC

Centene

$100.26

0.04 (0.04%)

MOH

Molina Healthcare

$71.86

-0.26 (-0.36%)

WCG

WellCare

$194.65

1.44 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

ALSWF

Absolute Software

06:11
02/21/18
02/21
06:11
02/21/18
06:11
Conference/Events
Absolute Software management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ABMD

Abiomed

$270.48

2.74 (1.02%)

06:10
02/21/18
02/21
06:10
02/21/18
06:10
Conference/Events
Abiomed management to meet with Piper Jaffray »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Mar

ERII

Energy Recovery

$7.55

-0.25 (-3.21%)

06:10
02/21/18
02/21
06:10
02/21/18
06:10
Hot Stocks
Energy Recovery awarded $6.2M for desalination projects in Saudi Arabia »

Energy Recovery announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 15

    May

VLKAY

Volkswagen

$41.00

-1.54 (-3.62%)

06:10
02/21/18
02/21
06:10
02/21/18
06:10
Periodicals
Volkswagen, German union IG Metall reach wage agreement, Reuters reports »

Volkswagen and German…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INOV

Inovalon

06:09
02/21/18
02/21
06:09
02/21/18
06:09
Recommendations
Inovalon analyst commentary  »

Inovalon guidance leaves…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

SLCA

U.S. Silica

$30.75

-0.8 (-2.54%)

06:08
02/21/18
02/21
06:08
02/21/18
06:08
Earnings
U.S. Silica reports Q4 EPS 89c, consensus 54c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 30

    May

DDAIF

Daimler AG

$86.88

-3.41 (-3.78%)

06:08
02/21/18
02/21
06:08
02/21/18
06:08
Periodicals
Daimler aims to begin serial production of eActros truck in 2021, Reuters says »

Daimler plans to commence…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGI

Alamos Gold

$5.37

-0.25 (-4.45%)

06:07
02/21/18
02/21
06:07
02/21/18
06:07
Hot Stocks
Alamos Gold reports 2017 year-end mineral reserves up 28% »

Alamos Gold reported its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

INOV

Inovalon

06:06
02/21/18
02/21
06:06
02/21/18
06:06
Earnings
Inovalon sees 2018 EPS 31c-35c, consensus 36c »

Sees 2018 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

UTHR

United Therapeutics

$134.96

0.03 (0.02%)

06:05
02/21/18
02/21
06:05
02/21/18
06:05
Earnings
United Therapeutics reports Q4 EPS $3.89, consensus $3.89 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

CLNE

Clean Energy

$1.43

-0.03 (-2.05%)

06:05
02/21/18
02/21
06:05
02/21/18
06:05
Hot Stocks
Clean Energy, HTA announce a new partnership »

The Harbor Trucking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

JELD

Jeld-Wen

$37.64

0.09 (0.24%)

06:03
02/21/18
02/21
06:03
02/21/18
06:03
Earnings
Jeld-Wen sees 2018 revenue growth 8.0%-11.0%, consensus $4.09B »

Sees 2018 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 28

    Mar

T

AT&T

$36.77

-0.37 (-1.00%)

, CHTR

Charter

$358.77

-6.89 (-1.88%)

06:03
02/21/18
02/21
06:03
02/21/18
06:03
Periodicals
FCC expected to publish reversal of net neutrality rules, Reuters reports »

The FCC is expected to…

T

AT&T

$36.77

-0.37 (-1.00%)

CHTR

Charter

$358.77

-6.89 (-1.88%)

CMCSA

Comcast

$39.47

-0.32 (-0.80%)

CMCSK

Comcast

VZ

Verizon

$48.92

-1.23 (-2.45%)

NFLX

Netflix

$278.55

0.03 (0.01%)

GOOG

Alphabet

$1,102.46

7.66 (0.70%)

GOOGL

Alphabet Class A

$1,103.59

8.09 (0.74%)

AMZN

Amazon.com

$1,468.35

19.66 (1.36%)

FB

Facebook

$176.01

-1.35 (-0.76%)

TWTR

Twitter

$32.84

-0.22 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 18

    Mar

  • 20

    Mar

CVEO

Civeo

$3.34

-0.03 (-0.89%)

06:03
02/21/18
02/21
06:03
02/21/18
06:03
Hot Stocks
Civeo receives approval for pending acquisition of Noralta Lodge »

Civeo announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

PTEN

Patterson-UTI

$17.96

-0.13 (-0.72%)

06:03
02/21/18
02/21
06:03
02/21/18
06:03
Hot Stocks
Patterson-UTI acquires Superior QC »

Patterson-UTI announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

Jeld-Wen

$37.64

0.09 (0.24%)

06:01
02/21/18
02/21
06:01
02/21/18
06:01
Earnings
Jeld-Wen reports Q4 adjusted EPS 26c, consensus 42c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 28

    Mar

AMZN

Amazon.com

$1,468.35

19.66 (1.36%)

06:00
02/21/18
02/21
06:00
02/21/18
06:00
Periodicals
Amazon tried to buy smart lock maker August Home for $100M, The Information says »

Amazon tried to buy smart…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 18

    Mar

VRX

Valeant

$18.58

-0.3 (-1.59%)

, TEVA

Teva

$19.98

-0.92 (-4.40%)

05:55
02/21/18
02/21
05:55
02/21/18
05:55
Recommendations
Valeant, Teva analyst commentary  »

Deutsche sees rifamycin…

VRX

Valeant

$18.58

-0.3 (-1.59%)

TEVA

Teva

$19.98

-0.92 (-4.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 13

    May

  • 18

    Jun

  • 27

    Aug

BT

BT Group

$16.24

0.05 (0.31%)

05:49
02/21/18
02/21
05:49
02/21/18
05:49
Upgrade
BT Group rating change  »

BT Group upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.